All In Biotech

Investigational drug · Phase 3

Mocertatug rezetecan

Also called: Mo-Rez

Not approved by FDA. In 6 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Ovarian Neoplasms, Neoplasms, Endometrial, Tumours, Gynecological.

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

6

6 still active

All registered trials

7

Any phase or sponsor naming "Mocertatug rezetecan"

First trial start

2025

Mar 4, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Mocertatug rezetecan", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Ovarian Neoplasms
  • Neoplasms, Endometrial
  • Tumours, Gynecological

Approved drugs for the same conditions: Endometrial cancer · Oncology

Largest trials

Live from ClinicalTrials.gov: studies naming "Mocertatug rezetecan" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 2 on PubMed

Also in development for Ovarian Neoplasms

  • Anlotinib hydrochlorideAL3818, CatequentenibPhase 312 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Alveolar Soft Part Sarcoma, Metastatic Colorectal Cancer, Endometrial Neoplasms

  • R-DXdDS 6000a, MK-5909Phase 310 trials

    Merck & Co. · Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer

  • OlomorasibLY3537982Phase 36 trials

    Eli Lilly · Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis

  • AL58805Phase 22 trials

    Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms

  • BMX-001Phase 21 trial

    BioMimetix JV, LLC · Ovarian Neoplasms, Endometrial Cancer, Endometrial Neoplasm

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from GSK.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.